The effect of pregabalin on pain-related sleep interference in diabetic peripheral neuropathy or postherpetic neuralgia: A review of nine clinical trials

Current Medical Research and Opinion

Volumn 26, Issue 10, 2010, Pages 2411-2419

  Roth, Thomas ^a   Van Seventer, Robert ^b   Murphy, T Kevin ^c  

^a HENRY FORD HEALTH SYSTEM   (United States)

^b AMPHIA HOSPITAL   (Netherlands)

^c PFIZER INC   (United States)

Author keywords

Diabetic peripheral neuropathy (DPN); Neuropathic pain; Postherpetic neuralgia (PHN); Pregabalin; Sleep interference

Indexed keywords

ACETYLSALICYLIC ACID; BENZODIAZEPINE; PARACETAMOL; PLACEBO; PREGABALIN;

ANALGESIA; AROUSAL; CLINICAL TRIAL; DAYTIME SOMNOLENCE; DIABETIC NEUROPATHY; DIABETIC PATIENT; DIZZINESS; DRUG DOSE ESCALATION; DRUG EFFECT; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; DYSPNEA; HEADACHE; HUMAN; LOW DRUG DOSE; MEDLINE; PAIN ASSESSMENT; PERIPHERAL EDEMA; POSTHERPETIC NEURALGIA; REVIEW; SLEEP; SLEEP DISORDER; SLEEP TIME; SNORING; SOMNOLENCE; XEROSTOMIA;

ANALGESICS; DIABETIC NEUROPATHIES; DOUBLE-BLIND METHOD; GAMMA-AMINOBUTYRIC ACID; HUMANS; NEURALGIA, POSTHERPETIC; PAIN MEASUREMENT; PLACEBOS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SLEEP; SLEEP DISORDERS; TREATMENT OUTCOME;

EID: 77956763017     PISSN: 03007995     EISSN: 14734877     Source Type: Journal    
DOI: 10.1185/03007995.2010.516142     Document Type: Review

References (49)

1. Merskey H, Bogduk N. Classification of Chronic Pain. In: Descriptions of Chronic Pain Syndromes and Definition of Pain Terms. Seattle: IASP Press, 1994
2. Sadosky A, McDermott AM, Brandenburg NA, et al. A review of the epidemiology of painful diabetic peripheral neuropathy, postherpetic neuralgia, and less commonly studied neuropathic pain conditions. Pain Pract 2008;8:45-56
3. Carter GT, Galer BS. Advances in the management of neuropathic pain. Phys Med Rehabil Clin N Am 2001;12:447-459
4. Attal N, Cruccu G, Haanpää M, et al. EFNS guidelines on pharmacological treatment of neuropathic pain. Eur J Neurol 2006;13:1153-1169
5. Backonja MM, Serra J. Pharmacologic management part 1: better-studied neuropathic pain diseases. Pain Med 2004;5(Suppl. 1):S28-47 (Pubitemid 38404455)
6. Guay DR. Adjunctive agents in the management of chronic pain. Pharmacotherapy 2001;21:1070-1081
7. McCracken LM, Iverson GL. Disrupted sleep patterns and daily functioning in patients with chronic pain. Pain Res Manag 2002;7:75-79
8. Moote CA, Knill RL, Skinner MI. Morphine disrupts nocturnal sleep in a dose dependent fashion [abstract]. Anesth Analg 1989;68:S200
9. Morin CM, Gibson D, Wade J. Self-reported sleep and mood disturbance in chronic pain patients. Clin J Pain 1998;14:311-314
10. Smith MT, Perlis ML, Smith MS, et al. Sleep quality and presleep arousal in chronic pain. J Behav Med 2000;23:1-13
11. Galer BS, Gianas A, Jensen MP. Painful diabetic polyneuropathy: epidemiology, pain description, and quality of life. Diabetes Res Clin Pract 2000;47:123-128
12. Nicholson B, Verma S. Comorbidities in chronic neuropathic pain. Pain Med 2004;5(Suppl. 1):S9-S27
13. Gore M, Brandenburg NA, Dukes E, et al. Pain severity in diabetic peripheral neuropathy is associated with patient functioning, symptom levels of anxiety and depression, and sleep. J Pain Symptom Manage 2005;30:374-385
14. Argoff CE. The coexistence of neuropathic pain, sleep, and psychiatric disorders: a novel treatment approach. Clin J Pain 2007;23:15-22
15. Bazil CW. Effects of antiepileptic drugs on sleep structure: are all drugs equal? CNS Drugs 2003;17:719-728
16. Legros B, Bazil CW. Effects of antiepileptic drugs on sleep architecture: a pilot study. Sleep Med 2003;4:51-55
17. 2d ligands: novel modulators of neurotransmission. Trends Pharmacol Sci 2007;28:75-82
18. Goldstein DJ, Lu Y, Detke MJ, et al. Duloxetine vs. placebo in patients with painful diabetic neuropathy. Pain 2005;116:109-118
19. 2-delta) subunit as a target for antiepileptic drug discovery. Epilepsy Res 2007;73:137-150
20. 3H]norepinephrine release from rat neocortical slices by gabapentin and pregabalin. J Pharmacol Exp Ther 2000;295:1086-1093
21. \+-evoked glutamate release from rat neocortical and hippocampal slices by gabapentin. Neurosci Lett 2000;280:107-110
22. Fehrenbacher JC, Taylor CP, Vasko MR. Pregabalin and gabapentin reduce release of substance P and CGRP from rat spinal tissues only after inflammation or activation of protein kinase C. Pain 2003;105:133-141
23. 2\+ influx by gabapentin and pregabalin in the human neocortex. Neuropharmacology 2002;42:229-236
24. 3H]glutamate from rat caudial trigeminal nucleus slices. Pain 2001;93:191-196
25. 2-d-1 subunit of voltage-dependent calcium channels as a molecular target for pain mediating the analgesic actions of pregabalin. Proc Natl Acad Sci USA 2006;103:17537-17542
26. Kubota T, Fang J, Meltzer LT, et al. Pregabalin enhances nonrapid eye movement sleep. J Pharmacol Exp Ther 2001;299:1095-1105
27. G-subunit of T-type calcium channels. Proc Natl Acad Sci USA 2004;101:18195-18199
28. De Haas S, Otte A, de Weerd A, et al. Exploratory polysomnographic evaluation of pregabalin on sleep disturbance in patients with epilepsy. J Clin Sleep Med 2007;3:473-478
29. Russell IJ, Crofford LJ, Leon T, et al. The effects of pregabalin on sleep disturbance symptoms among individuals with fibromyalgia syndrome. Sleep Med 2009;10:604-610
30. Dworkin RH, Corbin AE, Young Jr JP, et al. Pregabalin for the treatment of postherpetic neuralgia: a randomized, placebo-controlled trial. Neurology 2003;60:1274-1283
31. Freynhagen R, Strojek K, Griesing T, et al. Efficacy of pregabalin in neuropathic pain evaluated in a 12-week, randomised, double-blind, multicentre, placebo-controlled trial of flexible-and fixed-dose regimens. Pain 2005; 115:254-263
32. Lesser H, Sharma U, LaMoreaux L, et al. Pregabalin relieves symptoms of painful diabetic neuropathy: a randomized controlled trial. Neurology 2004; 63:2104-2110
33. Richter RW, Portenoy R, Sharma U, et al. Relief of painful diabetic peripheral neuropathy with pregabalin: a randomized, placebo-controlled trial. J Pain 2005;6:253-260
34. Rosenstock J, Tuchman M, LaMoreaux L, et al. Pregabalin for the treatment of painful diabetic peripheral neuropathy: a double-blind, placebo-controlled trial. Pain 2004;110:628-638
35. Sabatowski R, Gálvez R, Cherry DA, et al. Pregabalin reduces pain and improves sleep and mood disturbances in patients with post-herpetic neuralgia: results of a randomised, placebo-controlled clinical trial. Pain 2004;109:26-35
36. Tö lle T, Freynhagen R, Versavel M, et al. Pregabalin for relief of neuropathic pain associated with diabetic neuropathy: a randomized, double-blind study. Eur J Pain 2008;12:203-213
37. Van Seventer R, Feister HA, Young Jr JP, et al. Efficacy and tolerability of twice-daily pregabalin for treating pain and related sleep interference in postherpetic neuralgia: a 13-week, randomized trial. Curr Med Res Opin 2006;22:375-384
38. Arezzo JC, Rosenstock J, Lamoreaux L, et al. Efficacy and safety of pregabalin 600 mg/d for treating painful diabetic peripheral neuropathy: a double-blind placebo-controlled trial. BMC Neurol 2008;8:33
39. Hays R, Stewart A. Sleep Measures. In: Stewart A, Ware Jr J (eds). Measuring Functioning and Well-being. Durham, NC: The RAND Corporation, 1992:235-259
40. Hays RD, Martin SA, Sesti AM, et al. Psychometric properties of the Medical Outcomes Study Sleep measure. Sleep Med 2005;6:41-44
41. Mundel T, Martin S, LaMoreaux L, et al. Polysomnographic evaluation of sleep disturbance in neuropathic pain. Sleep 2003;26 (abstract suppl.):A354
42. Roehrs T, Roth T. Sleep and pain: interaction of two vital functions. Semin Neurol 2005;25:106-116
43. Buvanendran A, Kroin JS, Della Valle CJ, et al. Perioperative oral pregabalin reduces chronic pain after total knee arthroplasty: a prospective, randomized, controlled trial. Anesth Analg 2010;110:199-207
44. Kurokawa I, Kumano K, Murakawa K. Clinical correlates of prolonged pain in Japanese patients with acute herpes zoster. J Int Med Res 2002; 30:56-65
45. Knutson KL. Impact of sleep and sleep loss on glucose homeostasis and appetite regulation. Sleep Med Clin 2007;2:187-197
46. Knutson KL, Ryden AM, Mander BA, et al. Role of sleep duration and quality in the risk and severity of type 2 diabetes mellitus. Arch Intern Med 2006; 166:1768-1774
47. Knutson KL, Spiegel K, Penev P, et al. The metabolic consequences of sleep deprivation. Sleep Med Rev 2007;11:163-178
48. Knutson KL, Van Cauter E. Associations between sleep loss and increased risk of obesity and diabetes. Ann NY Acad Sci 2008;1129:287-304
49. Tanenberg R. Diabetic peripheral neuropathy: painful or painless. Hosp Physician 2009;45:1-8